INTERVEXION THERAPEUTICS
InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Their lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 has received US FDA Fast Track Designation, and is being studied in an ongoing Phase 2 proof-of-concept study (STAMPOUT; NCT03336866). They are also developing a novel vaccine (IXT-v100) against methamphetamine, which is in Preclinical Development.
INTERVEXION THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Little Rock, Arkansas, United States
Country:
United States
Website Url:
http://www.intervexion.com
Total Employee:
51+
Status:
Active
Contact:
501.554.2377
Total Funding:
52.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Mobile Non Scaleable Content Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Adrenomed
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Ascentage Pharma
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Enteris BioPharma
Enteris BioPharma is a privately held, clinical stage biopharmaceutical company
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
UNION therapeutics A/S
UNION therapeutics A/S is a privately held, clinical stage, pharmaceutical company.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - InterveXion Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - InterveXion Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - InterveXion Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - InterveXion Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - InterveXion Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - InterveXion Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - InterveXion Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - InterveXion Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - InterveXion Therapeutics
Official Site Inspections
http://www.intervexion.com Semrush global rank: 9.72 M Semrush visits lastest month: 114
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
